Notícias

Treatments for coronavirus disease 2019, which iscaused by severe acute respiratory syndrome coronavirus-2(SARS-CoV-2), are urgently needed but remain limited. SARSCoV-2...

O trabalho “Otimização da síntese de isoniazida com reatores de microfluídica” rendeu ao Instituto de Tecnologia em Fármacos (Farmanguinhos /...

Given the emergence of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which particularly threatens older people with comorbidities such as diabetes...

O XII Seminário Internacional Patentes, Inovação e Desenvolvimento (Sipid) aconteceu nessa terça, dia 7, em formato virtual. Este ano, o...

Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has witnessed a devastating global...

COVID-19 is characterized by vascular inflammation and thrombosis, including elevations in P-selectin, a mediator of inflammation released by endothelial cells....

After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to...

The emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 and the reduced effectiveness over time...

O advogado Pedro Marcos Barbosa foi o homenageado na 6ª edição do Prêmio Denis Barbosa, em cerimônia realizada no dia...

Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the...

A new coronavirus disease named COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide. However, there...

Anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines elicit lower humoral responses in solid-organ transplant recipients. This is the first...